肺癌筛查CT所见的疑似感染性和炎性肺部异常的管理与结局
该回顾性研究分析3800例肺癌筛查患者中331例(8.7%)疑似感染或炎性肺部异常,常见表现为磨玻璃影、树芽征、实变和簇状影,78.5%在随访中消退,仅0.6%伴恶性肿瘤,作者提出的保守管理算法理论上可减少82.6%不必要随访影像而不漏诊恶性肿瘤。
要点
- 肺癌筛查中约8.7%患者见疑似感染或炎性肺部异常,78.5%为多灶性。
- 此类异常常见描述为磨玻璃影(46.8%)、树芽征(16.9%)、实变(12.4%)、簇状影(20.2%)。
- 78.5%在随访影像上消退,仅0.6%伴恶性肿瘤且均为实变。
核心结论
- 肺癌筛查中疑似急性感染或炎性肺部异常常见,多灶性者多可随访消退,不足1%伴恶性肿瘤。
- 作者提出的保守管理算法可标准化推荐并减少不必要影像,理论上减少82.6%不必要随访影像且未漏诊一例恶性肿瘤。
研究设计与样本
- 回顾性研究,纳入2014年6月至2019年4月已建立肺癌筛查项目中的6314次低剂量CT检查、3800例患者。
- 复习放射学报告,识别疑似感染或炎性肺部异常患者,分析影像描述、Lung-RADS分类、推荐和临床结局。
- 基于影像描述、结局和大于2%的恶性风险阈值,开发随访算法以减少额外影像而不影响癌症检出。
关键影像表现/征象
- 331/3800(8.7%)患者(男178例、女153例;平均年龄66岁,范围53-87岁)有归因于感染或炎症的肺部表现。
- 异常以S修饰符报告为潜在显著发现者149/331(45.0%),作为决定Lung-RADS分类的主结节者96/331(29.0%)。
- 异常为多发或多灶性者260/331(78.5%)。
- 常见描述为磨玻璃影155/331(46.8%)、树芽征56/331(16.9%)、实变41/331(12.4%)、簇状影67/331(20.2%)。
诊断标准与关键数值
- 恶性风险阈值为大于2%,用于开发随访算法以减少额外影像而不影响癌症检出。
- 331例中2例(0.6%)伴恶性肿瘤,且两例均有实变。
- 随访12个月或更短时间内行筛查外胸部CT者264/331(79.8%),6个月或更短时间内者186/331(56.2%)。
- 260/331(78.5%)病灶在随访影像上消退。
- 理论采用所提出的疑似感染和炎性表现管理算法,减少不必要随访影像82.6%,且未漏诊一例恶性肿瘤。
临床应用与阅片要点
- 作者提出基于影像描述、结局和大于2%恶性风险阈值的随访算法,理论上可减少82.6%不必要随访影像且未漏诊恶性肿瘤。
- 疑似感染或炎性异常多灶性常见(78.5%),随访中78.5%消退,恶性伴发率0.6%且均为实变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Incidental findings are frequently encountered during lung cancer screening (LCS). Limited data describe the prevalence of suspected acute infectious and inflammatory lung processes on LCS and how they should be managed. OBJECTIVE. The purpose of this study was to determine the prevalence, radiologic reporting and management, and outcome of suspected infectious and inflammatory lung processes identified incidentally during LCS and to propose a management algorithm. METHODS. This retrospective study included 6314 low-dose CT (LDCT) examinations performed between June 2014 and April 2019 in 3800 patients as part of an established LCS program. Radiology reports were reviewed, and patients with potentially infectious or inflammatory lung abnormalities were identified and analyzed for descriptors of imaging findings, Lung-RADS designation, recommendations, and clinical outcomes. Using the descriptors, outcomes, and a greater than 2% threshold risk of malignancy, a follow-up algorithm was developed to decrease additional imaging without affecting cancer detection. RESULTS. A total of 331/3800 (8.7%) patients (178 men, 153 women; mean age [range], 66 [53-87] years) undergoing LCS had lung findings that were attributed to infection or inflammation. These abnormalities were reported as potentially significant findings using the S modifier in 149/331 (45.0%) and as the dominant nodule used to determine the Lung-RADS category in 96/331 (29.0%). Abnormalities were multiple or multifocal in 260/331 (78.5%). Common descriptors were ground-glass (155/331; 46.8%), tree-in-bud (56/331; 16.9%), consolidation (41/331; 12.4%), and clustered (67/331; 20.2%) opacities. A follow-up chest CT outside of screening was performed within 12 months or less in 264/331 (79.8%) and within 6 months or less in 186/331 (56.2%). A total of 260/331 (78.5%) opacities resolved on follow-up imaging. Two malignancies (2/331; 0.6%) were associated with these abnormalities and both had consolidations. Theoretic adoption of a proposed management algorithm for suspected infectious and inflammatory findings reduced unnecessary follow-up imaging by 82.6% without missing a single malignancy. CONCLUSION. Presumed acute infectious or inflammatory lung abnormalities are frequently encountered in the setting of LCS. These opacities are commonly multifocal and resolve on follow-up. Less than 1% are associated with malignancy. CLINICAL IMPACT. Adoption of a conservative management algorithm can standardize recommendations and reduce unnecessary imaging without increasing the risk of missing a malignancy.
引用
- Mendoza DP, Chintanapakdee W, Zhang EW, et al. Management and Outcomes of Suspected Infectious and Inflammatory Lung Abnormalities Identified on Lung Cancer Screening CT. AJR Am J Roentgenol. 2020. PMID: 33377416. doi:10.2214/AJR.20.25124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。